← Eichor
Study identifier: NCT07017413 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Predictors For Transosseous Maxillary Sinus Lift Complications

Condition: Sinus Lift Surgery Complications · Maxillary Sinus Elevation  ·  Sponsor: University of Baghdad

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This prospective cohort study aims to identify clinical and anatomical predictors for complications following transosseous maxillary sinus lift procedures using the Versah (Densah burs) technique. The study focuses on patients undergoing transcrestal sinus floor elevation without a lateral window, with or without simultaneous dental implant placement. Variables such as residual bone height, sinus membrane thickness, bone density, and patient-related factors are being evaluated. The objective is to enhance risk stratification and optimize treatment planning for transosseous sinus augmentation.

This description comes directly from the study's public registry record.

Talk to the study team

Mustafa Al-Jamal, BDS, MSc, PhD  ·  +9647704681045  ·  dr.mustafa.faisal9@gmail.com

Ahmed Quisi, BDS. FIBMS  ·  +9647811896313  ·  ahmed.fadhil@codental.uobaghdad.edu.iq

Always discuss trial participation with your own doctor first.

Locations (2)

College of Dentistry , University of BaghdadBaghdad, Bab Almodaum, IraqRecruiting
Planto clinicBaghdad, Mansour, IraqRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07017413